Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on: February 20,2024

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on:February 20,2024

New study may advance use of spinal cord stimulation for chemotherapy-related pain and cancer treatment

byJohns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Johns Hopkins University School of Medicine say they have evidence from a new study in rats that spin

Updated on: January 13,2024

New study may advance use of spinal cord stimulation for chemotherapy-related pain and cancer treatment

byJohns Hopkins University School of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Johns Hopkins University School of Medicine say they have evidence from a new study in rats that spin

Updated on:January 13,2024

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on: April 14,2024

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on:April 14,2024

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on: April 02,2024

Forty-three percent of melanoma patients have chronic complications from immunotherapies

by Vanderbilt University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Chronic side effects among

Updated on:April 02,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on: January 12,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on:January 12,2024

Breast MRI effective at detecting cancer in dense breasts, finds study

byRadiological Society of North AmericaForest plots show the incremental cancer detection rate (CDR) per 1000 screenings per modality. (A) Studies with handheld US. (B) Studies with automated wh

Updated on: January 23,2024

Breast MRI effective at detecting cancer in dense breasts, finds study

byRadiological Society of North AmericaForest plots show the incremental cancer detection rate (CDR) per 1000 screenings per modality. (A) Studies with handheld US. (B) Studies with automated wh

Updated on:January 23,2024

Determinants of overall survival in metastatic uveal melanoma identified

by Elana GotkineFactors associated with improved survival in metastatic uveal melanoma include female sex and use of anti‐cytotoxic T lymphocyte-associated antigen (CTLA)‐4 and anti‐programmed cell de

Updated on: January 22,2024

Determinants of overall survival in metastatic uveal melanoma identified

by Elana GotkineFactors associated with improved survival in metastatic uveal melanoma include female sex and use of anti‐cytotoxic T lymphocyte-associated antigen (CTLA)‐4 and anti‐programmed cell de

Updated on:January 22,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on: June 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on:June 28,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on: April 14,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on:April 14,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on: January 04,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on:January 04,2024

'Junk DNA' affects inherited cancer risk

by Cancer Research UKCredit: CC0 Public DomainA person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed a

Updated on: March 13,2024

'Junk DNA' affects inherited cancer risk

by Cancer Research UKCredit: CC0 Public DomainA person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed a

Updated on:March 13,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on: April 09,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on:April 09,2024